Latest 8-K filings

HNI Corporation announced second quarter 2026 financial results, with non-GAAP diluted EPS of $1.27, a 14% year-over-year increase, and an improved outlook for the full year.

Jones Lang LaSalle Incorporated announced a record second quarter with diluted EPS soaring 100% year-over-year to $4.59, driven by strong performance across Advisory and Capital Markets services.

Tvardi Therapeutics has chosen ulcerative colitis as the initial indication for its STAT3 inhibitor, TTI-109, following promising Phase 1 study results.

Soluna Holdings, Inc. will release its second quarter 2026 financial results on August 13, 2026, and will host a conference call and webcast.

Intercontinental Exchange (ICE) announced robust second quarter 2026 financial results, showcasing growth in revenues, earnings per share, and operating income, alongside a significant increase in share repurchase authorization.

Ranpak Holdings Corp. reported a 14.0% increase in net revenue to $105.2 million for Q2 2026, driven by strong automation growth, though net loss widened slightly to $7.9 million.

Leonardo DRS announced robust second quarter 2026 financial results, including a 10% revenue increase and a 59% surge in net earnings, alongside the strategic acquisition of Raft for $450 million.

Upbound Group, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting consolidated revenue of $1.163 billion and reaffirming full-year guidance for Adjusted EBITDA and non-GAAP diluted EPS.

TriNet Group, Inc. reported strong second quarter 2026 financial results, including a 50% year-over-year increase in GAAP Earnings per Diluted Share to $1.15, and raised its full-year 2026 earnings guidance.

Huntington Ingalls Industries (HII) announced robust second quarter 2026 financial results, exceeding expectations with significant revenue growth and a raised full-year shipbuilding revenue outlook.

Stagwell Inc. announced robust financial results for the second quarter of 2026, showcasing significant year-over-year growth in revenue, net new business, and adjusted EPS, alongside a raised full-year guidance.

International Paper announced its second quarter 2026 financial results, reporting a net sales of $6.00 billion and a loss from continuing operations of $12 million.

Baxter International Inc. announced second-quarter 2026 results, exceeding expectations with sales growth and raising its full-year financial outlook.

Extreme Networks, Inc. has entered into a new 5-year, $500 million revolving credit facility, replacing its existing agreement and providing capital for general corporate purposes.

CCC Intelligent Solutions reported strong second quarter 2026 results with 9.8% revenue growth and robust adjusted EBITDA margins, driven by expanded AI adoption.

NorthWestern Energy reported strong Q2 2026 results, with GAAP diluted EPS of $0.40 and affirmed 2026 guidance, while making significant progress on its merger with Black Hills Corporation.

Affiliated Managers Group, Inc. announced record Assets Under Management (AUM) of $942 billion and a 54% year-over-year increase in Economic EPS to $8.29 for the second quarter of 2026.

Laureate Education, Inc. announced robust financial results for the second quarter of 2026, exceeding expectations and leading to an increase in full-year guidance, alongside a significant boost to its share repurchase program.

Mid-America Apartment Communities, Inc. (MAA) issued a press release correcting a previous statement regarding its 2026 Same Store portfolio NOI growth guidance.

Hilton Grand Vacations reported strong Q2 2026 results with increased revenues and Adjusted EBITDA, driven by healthy tour growth and disciplined cost management, while reiterating full-year guidance.

Allegro MicroSystems announced a 27% year-over-year sales increase to $259 million for its first quarter of fiscal year 2027, driven by strong performance in data center and automotive sectors.

Altria Group, Inc. announced its second-quarter and first-half 2026 financial results, narrowing its full-year adjusted diluted EPS guidance.

Bristol Myers Squibb reported strong second quarter 2026 financial results, driven by its Growth Portfolio, and raised its full-year revenue and EPS guidance.

Bicycle Therapeutics reported Q2 2026 financial results, highlighting positive clinical data for nuzefatide and zelenectide, an expanded advisory board, and a cash runway extending into 2030.

Myers Industries announced a significant amendment to its loan agreement, extending maturity dates and establishing a new term loan facility, alongside robust second-quarter financial results showing substantial year-over-year growth in revenue and profitability.

EyePoint, Inc. announced the completion of enrollment in its pivotal Phase 3 clinical trials for DURAVYU in treating diabetic macular edema (DME), with topline data expected in Q4 2027.

Phathom Pharmaceuticals announced record Q2 2026 net revenues of $74.3 million, an 88% increase year-over-year, alongside a significant reduction in operating expenses and achievement of operating profitability excluding stock-based compensation.

Terex Corporation announced robust second quarter 2026 financial results, with sales up 50.5% and adjusted net income of $156 million, leading to an increased full-year financial forecast.

Pagaya Technologies Ltd. announced strong second quarter 2026 financial results, exceeding expectations and leading to an increase in full-year net income guidance.

AMC Global Media announced its second quarter 2026 financial results, highlighting a significant content licensing agreement with Netflix for The Walking Dead Universe and increased full-year guidance.